Dr Roger Brito: What Patients Should Know About Alternative Payment Models, OCM
January 9th 2018The healthcare triangle (patients, payers, and providers) begins with the patient, so we should include the patient in some of the decision-making, said Roger Brito, DO, national director for oncology, Aetna.
Read More
Dr Mark Fendrick on Indication-Based Drug Pricing in Cancer Care
January 7th 2018The fact that you have certain drugs that treat numerous cancers, and that they may treat 1 cancer different or better than another, would suggest that we should probably have differential pricing models, said A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design at the University of Michigan.
Read More
Judy Berger on What Southwest Airlines Is Doing in Oncology
January 4th 2018Southwest Airlines has set up a split fill program, pharmacy benefit manager, health advocacy program, and a cancer resource guide for employees, said Judy Berger, senior manager, benefits planning, Southwest Airlines.
Read More
Sarah Cevallos: Physicians Need More Data to Determine if 2-Sided Risk is Appropriate
December 26th 2017Until more data is available, it’s difficult for a practice or physician group to make an accurate assessment of whether or not 2-sided risk is appropriate, said Sarah Cevallos, chief revenue cycle officer, Florida Cancer Specialists. Physicians would need to see clear metrics in order to know if they will be achievable.
Read More
Dr Lucio Gordan: Improving Population Health Through Alternative Payment Models
December 8th 2017As people get more empowered and more informed with data, such as their own electronic medical records, they will utilize the information to do better for themselves and improve their health, said Lucio Gordan, MD, of Florida Cancer Specialists.
Read More
Dr Ira Klein on Pharmaceutical Interest in Alternative Payment Models
December 7th 2017Pharmaceutical companies would like to see value-based contracts that are multi-year and over large populations, said Ira Klein, MD, MBA, FACP, senior director of healthcare quality strategy for the Strategic Customer Group at Janssen Pharmaceuticals.
Read More
Dr Ira Klein Outlines the Biggest Challenge of Value-Based Drug Pricing
November 5th 2017The healthcare industry is getting better at creating value-based drug pricing arrangements, and even if they never dominate the market, there will always be a place for these contracts, said Ira Klein, MD, MBA, FACP, senior director of healthcare quality strategy for the Strategic Customer Group at Janssen Pharmaceuticals.
Read More
Stakeholders Weigh-in on Payment Reform in Cancer Care
October 25th 2017Tuple Health, a healthcare technology startup, interviewed some of the stakeholders participating in value-based care delivery and OCM, to gain their perspective of the state of cancer care and healthcare reform. The results were presented at the Community Oncology Alliance Payer Exchange Summit on Oncology Payment Reform.
Read More
The Commercial Payer OCM Experience: Year 1
October 25th 2017Representatives from 3 payers who partnered with providers on the Oncology Care Model (OCM) took the stage at Community Oncology Alliance (COA)’s Payer Exchange Summit on Oncology Payment Reform to outline their experience with OCM and how it has differed from other care models.
Read More
Physicians Need Clearer Metrics Before Taking on 2-Sided Risk
October 25th 2017Before physicians will be more willing to take on 2-sided risk, there needs to be clearer metrics that the physicians know will be achievable, said Sarah Cevallos, chief revenue cycle officer at Florida Cancer Specialists.
Read More
Dr Lucio Gordan: How Practices and Payers Work Together to Implement OCM
October 24th 2017The implementation of the Oncology Care Model has brought profound culture changes to how oncologists take care of patients and how they operate practices, explained Lucio Gordan, MD, of Florida Cancer Specialists.
Read More
Will 2-Sided Risk Be a Reality in OCM?
October 24th 2017With the Oncology Care Model now in its second year, 3 representatives discussed learnings and how the program can change, as well as incentivizing physicians to accept 2-sided risk, the ability to engage additional payers, and the future of oncology bundle payments.
Read More
How Has the OCM Evolved? Year 1 Provider Updates
October 24th 2017Participants from 2 oncology community practices—an oncologist–administrator combination—shared their experience with implementing the Oncology Care Model (OCM) with attendees at the Community Oncology Alliance’s Payer Exchange Summit on Oncology Payment Reform, held October 23-24, in Tysons Corner, Virginia.
Read More
Rose Gerber's Outlook on the Evolution and Goals of COA'S CPAN
July 13th 2017The Community Oncology Alliance (COA) is forging ahead with its COA Patient Advocacy Network (CPAN), says Rose Gerber, director of patient advocacy for COA. The network’s major focuses include increasing its presence and making it easier for community practices to get involved.
Read More
Dr Barbara McAneny Discusses the Continuing Evolution of the COME HOME Model
July 7th 2017As more practices adopt the COME HOME model, they are adapting it to fit their needs, explained Barbara McAneny, MD, chief medical officer of New Mexico Oncology Hematology Consultants. However, some practices may not have the resources to keep up with data collection requirements while ramping up clinical interventions.
Read More
Dr Basit Chaudhry on the Impact of the Oncology Care Model
July 5th 2017As practices adopt the Oncology Care Model, practices should consider how this change will influence the practice and make efforts to continue engaging with the staff during this process, said Basit Chaudhry, MD, PhD, founder of Tuple Health.
Read More
Rose Gerber Discusses Cancer Survivorship's Lifelong Side Effects
June 30th 2017As a cancer survivor, Rose Gerber, director of patient advocacy for the Community Oncology Alliance, is personally aware of the many long-term issues that can arise during survivorship. These can include physical effects like bone health and emotional issues like the fear of recurrence.
Read More
Dr Bobby Green Explains How Changing Oncology Landscape Drives Big Data Initiatives
June 23rd 2017Oncologists envision a move towards using data to become a learning health system, which is aided by the changing landscape emphasizing quality and value, explained Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Read More
Leah Ralph on the Political and Legal Obstacles to 340B Reform
June 20th 2017The uncertainty in the political climate, along with the limited authority of the Health Resources and Services Administration within HHS, makes it difficult to predict whether the 340B program will be reformed in coming years, according to Leah Ralph, director of health policy at the Association of Community Cancer Centers.
Read More
Leah Ralph: ACCC Concerned About Potential Impact of MedPAC Proposals
May 28th 2017When MedPAC released several proposals to control Part B reimbursement costs, the ideas within them were not a surprise, explained Leah Ralph, director of health policy at the Association of Community Cancer Centers (ACCC). However, the ACCC has some concerns about how these proposals could impact cancer patients’ access to care.
Read More
Dr Daniel George on the Challenge of Cancer Vaccines
May 4th 2017Although Daniel George, MD, of the Duke Cancer Institute, sees value in cancer vaccines and expects they will start showing more benefit to patients, he acknowledges that a barrier to widespread use of cancer vaccines is that they don't show an immediate response.
Read More
Big Data Is Advancing Cancer Care, but Interoperability Remains a Challenge
May 3rd 2017There are 2 main ways big data has helped to advance cancer care, but the lack of interoperability in the United States limits some of the data that can be analyzed for quality purposes, explained Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Read More
Leah Ralph on ACCC's Concerns With GOP Healthcare Reform Proposals
April 30th 2017Negotiations among House Republicans have led to a compromise that would amend the American Health Care Act and the Association of Community Cancer Centers (ACCC) is concerned the amendment would undermine patient protections that are important for people with cancer, said Leah Ralph, director of health Policy at ACCC.
Read More
Linking Claims, Clinical Data Is Essential for a Learning Health System
April 28th 2017Is rubber meeting the road with big data in cancer care? “No…rather, not yet,” Green said at the 2017 Community Oncology Conference, April 26-27, held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland.
Read More